To compare tumor risk in the 4 Beckwith-Wiedemann syndrome (BWS) molecular subgroups: Imprinting Control Region 1 Gain of Methylation (ICR1-GoM), Imprinting Control Region 2 Loss of Methylation (ICR2-LoM), Chromosome 11p15 Paternal Uniparental Disomy (UPD), and Cyclin-Dependent Kinase Inhibitor 1C gene (CDKN1C) mutation.

Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol.

MUSSA, ALESSANDRO
First
;
MOLINATTO, Cristina;BALDASSARRE, GIUSEPPINA;RIBERI, EVELISE;RICCIO, ANDREA;FERRERO, Giovanni Battista
Last
2016

Abstract

To compare tumor risk in the 4 Beckwith-Wiedemann syndrome (BWS) molecular subgroups: Imprinting Control Region 1 Gain of Methylation (ICR1-GoM), Imprinting Control Region 2 Loss of Methylation (ICR2-LoM), Chromosome 11p15 Paternal Uniparental Disomy (UPD), and Cyclin-Dependent Kinase Inhibitor 1C gene (CDKN1C) mutation.
142
149
Beckwith-Wiedemann; meta-analysis; molecular group and tumor risk; oncological surveillance; tumor screening
Mussa, Alessandro; Molinatto, Cristina; Baldassarre, Giuseppina; Riberi, Evelise; Russo, Silvia; Larizza, Lidia; Riccio, Andrea; Ferrero, Giovanni Battista
File in questo prodotto:
File Dimensione Formato  
Cancer Risk in Beckwith-Wiedemann Syndrome.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.36 MB
Formato Adobe PDF
1.36 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1610930
Citazioni
  • ???jsp.display-item.citation.pmc??? 48
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 83
social impact